Allergy Relief Tablet
FDA Label NDC 69168-309

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Allegiant Health for the product Allergy Relief (NDC 69168-309). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, ask doctor before use if you have, when usingthis product, stop use and ask a doctor, if pregnant or breast-feeding, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient

Loratadine 10 mg

Purpose

Antihistamine

Uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: sneezing
runny nose itchy, watery eyes itching of the nose or throat

Warnings

Do not useif you have ever had an allergic reaction to this product or any of its ingredients

Ask Doctor Before Use If You Have

liver or kidney disease. Your doctor should determine if you need a different dose.

When Usingthis Product

do not take more than directed. Taking more than directed may cause drowsiness.

Stop Use And Ask A Doctor

if an allergic reaction to this product occurs. Seek medical help right away. You may report side effects to 1-888-952-0050

If Pregnant Or Breast-Feeding

ask a health professional before use

Keep Out Of Reach Of Children

In case of accidental overdose, contact a doctor or Poison Control Center immediately

Directions

Adults and children 6 years and over: 1 tablet daily: not more than 1 tablet in 24 hours
Children under 6 years of age: ask a doctor
Consumers with liver or kidney disease: ask a doctor

Inactive Ingredients

colloidal silicon dioxide, croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose.

* Please review the disclaimer below.